The new blood test detected 90% of early pancreatic cancers, vastly outperforming the standard tumor marker test.

A four-marker blood panel that includes two newly identified proteins detected stage I and II pancreatic cancer with 87.5 percent sensitivity at a 5 percent false-positive rate, according to findings ...

Researchers at Kanazawa University report the blood-based gene expression tests may enable early pancreatic cancer screening ...

Researchers at Kanazawa University report that blood-based gene expression tests may enable early pancreatic cancer screening ...

The ultra-sensitive test can find hidden signs of pancreatic cancer by looking for a key KRAS genetic mutation missed by ...

The new blood-based assay PAC-MANN-1 (protease activity–based cancer marker using magnetic nanosensor-1) identified pancreatic ductal adenocarcinoma (PDAC) across all stages with high specificity and ...

The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage for it to become widely available.

A highly sensitive blood test can detect signs of pancreatic cancer that standard methods often miss, according to results of ...

A new blood test detects pancreatic cancer in 65% of patients, up from 17% with the previous test. Northwestern Medicine Oncologist Dr. Akhil Chawla joins Good Day Chicago to discuss what it means ...

Add Yahoo as a preferred source to see more of our stories on Google. A new test aims to help detect pancreatic cancer more effectively and at an earlier stage. Photo: Getty Images Pancreatic cancer ...

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer that is often diagnosed at advanced stages and carries a low ...

Researchers at the Johns Hopkins Kimmel Cancer Center and its Skip Viragh Center for Pancreatic Cancer report that an ...